DHF
BNY MELLON HIGH YIELD STRATEGIES FUNDMarquee-fund ownership over time
This quarter's activity
New positions opened
None.
Positions exited
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q2 2026 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at BNY MELLON HIGH YIELD STRATEGIES FUND. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Apr 7, 2025 — the most recent Form 4 on file — not from today.
- Form 40001057861-25-000003Apr 7, 2025
- Form 40001057861-23-000001Apr 11, 2023
- Form 40001057861-22-000005Jul 8, 2022
- Form 40001057861-21-000001Jan 8, 2021
- Form 40001057861-20-000010Jun 24, 2020
- Form 40001057861-20-000005Mar 17, 2020
- Form 40001057861-20-000004Mar 16, 2020
- Form 40001057861-20-000003Mar 11, 2020
- Form 40001057861-20-000002Mar 9, 2020
- Form 40001057861-18-000020Dec 26, 2018
- Form 40001057861-18-000001Jan 26, 2018
- Form 40001180502-15-000009Dec 15, 2015
- Form 40001180502-15-000008Nov 18, 2015
- Form 40001180502-15-000007Oct 5, 2015
- Form 40001180502-15-000006Sep 28, 2015
Fundamentals
XBRL · BNY MELLON HIGH YIELD STRATEGIES FUNDNot enough XBRL history to plot. BNY MELLON HIGH YIELD STRATEGIES FUNDhasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for BNY MELLON HIGH YIELD STRATEGIES FUND — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementSep 26, 2025
- DEF 14AALL OTHER DEFINITIVE PROXY STATEMENTSJul 15, 2025
- SC 13G/AAMENDED SCHEDULE 13GOct 11, 2024
- SC 13G/AAMENDED SCHEDULE 13GJul 12, 2024
- DEF 14AALL OTHER DEFINITIVE PROXY STATEMENTSJul 3, 2024
- SC 13D/AFORM SC 13D/AFeb 29, 2024
- SC 13G/AAMENDED SCHEDULE 13GJan 17, 2024
- SC 13DFORM SC 13DDec 8, 2023
- DEF 14AALL OTHER DEFINITIVE PROXY STATEMENTSJul 5, 2023
- SC 13G/AAMENDED SCHEDULE 13GJan 30, 2023
- DEF 14APROXY STATEMENTAug 26, 2022
- DEF 14ADEFINITIVE PROXY FILINGJul 5, 2022
- SC 13G/AAMENDED SCHEDULE 13GJan 12, 2022
- DEF 14AALL OTHER DEFINITIVE PROXY STATEMENTSJul 6, 2021
- SC 13G/AAMENDED SCHEDULE 13GFeb 1, 2021
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q2 2026 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.